Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 436 AL 450

PUBMED

Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.

An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM.

Cell Stem Cell. 2012 Aug 3;11(2):253-63. doi: 10.1016/j.stem.2012.04.026.

0

0

0

PUBMED

Protein oxidation in Huntington disease.

Sorolla MA, Rodríguez-Colman MJ, Vall-llaura N, Tamarit J, Ros J, Cabiscol E.

Biofactors. 2012 May-Jun;38(3):173-85. doi: 10.1002/biof.1013. Review.

0

0

0

PUBMED

Huntington's disease: advocacy driving science.

Wexler NS.

Annu Rev Med. 2012;63:1-22. doi: 10.1146/annurev-med-050710-134457.

0

0

0

PUBMED

Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.

Weiss KR, Kimura Y, Lee WC, Littleton JT.

Genetics. 2012 Feb;190(2):581-600. doi: 10.1534/genetics.111.133710.

0

0

0

PUBMED

Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation.

Orvoen S, Pla P, Gardier AM, Saudou F, David DJ.

Neurosci Lett. 2012 Jan 24;507(2):127-32. doi: 10.1016/j.neulet.2011.11.063.

0

0

0

PUBMED

SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.

Wityak J, Prime ME, Brookfield FA, Courtney SM, Erfan S, Johnsen S, Johnson PD, Li M, Marston RW, Reed L, Vaidya D, Schaertl S, Pedret-Dunn A, Beconi M, Macdonald D, Muñoz-Sanjuan I, Dominguez C.

ACS Med Chem Lett. 2012 Oct 4;3(12):1024-8. doi: 10.1021/ml300241m.

0

0

0

PUBMED

Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease.

Ransome MI, Renoir T, Hannan AJ.

Neural Plast. 2012;2012:874387. doi: 10.1155/2012/874387. Review.

0

0

0

PUBMED

Therapy in Huntington's disease: where are we?

Nance MA.

Curr Neurol Neurosci Rep. 2012 Aug;12(4):359-66. doi: 10.1007/s11910-012-0277-4. Review.

0

0

0

PUBMED

Monitoring Huntington's disease progression through preclinical and early stages.

Tang C, Feigin A.

Neurodegener Dis Manag. 2012 Aug 1;2(4):421-435.

0

0

0

PUBMED

Does trans size matter in Huntington disease?

Ross OA, Singleton AB.

Neurology. 2012 Mar 6;78(10):686-7. doi: 10.1212/WNL.0b013e3182494d77. No abstract available.

0

0

0

PUBMED

Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.

Smith MM, Mills JA, Epping EA, Westervelt HJ, Paulsen JS; PREDICT-HD Investigators of the Huntington Study Group..

Neuropsychology. 2012 Sep;26(5):664-9. doi: 10.1037/a0029218.

0

0

0

PUBMED

R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.

Cepeda-Prado E, Popp S, Khan U, Stefanov D, Rodríguez J, Menalled LB, Dow-Edwards D, Small SA, Moreno H.

J Neurosci. 2012 May 9;32(19):6456-67. doi: 10.1523/JNEUROSCI.0388-12.2012.

0

0

0

PUBMED

Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice.

Murphy-Nakhnikian A, Dorner JL, Fischer BI, Bower-Bir ND, Rebec GV.

Neurosci Lett. 2012 Mar 14;512(1):1-5. doi: 10.1016/j.neulet.2011.12.040.

0

0

0

PUBMED

[Recommendations of good practices for molecular diagnosis of Huntington disease].

Ramos Arroyo MA, Trujillo-Tiebas MJ, Milá M; Grupo AEGH/CIBERER..

Med Clin (Barc). 2012 May 12;138(13):584-8. doi: 10.1016/j.medcli.2011.03.001. Spanish. No abstract available.

0

0

0

PUBMED

Anaesthesia and orphan disease: sugammadex in a patient with Huntington's disease undergoing thyroid lobectomy.

Khan MH, Banerjee A.

Eur J Anaesthesiol. 2012 Dec;29(12):593-5. doi: 10.1097/EJA.0b013e328356472a. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy